Jynarque
These highlights do not include all the information needed to use JYNARQUE safely and effectively. See full prescribing information for JYNARQUE. JYNARQUE (tolvaptan) tablets, for oral use Initial U.S. Approval: 2009
3febc0a1-9e5a-4ce0-843d-210f21d862c4
HUMAN PRESCRIPTION DRUG LABEL
Nov 8, 2022
Otsuka America Pharmaceutical, Inc.
DUNS: 008314390
Products 7
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
tolvaptan
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
tolvaptan
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (9)
tolvaptan
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
tolvaptan
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
tolvaptan
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
tolvaptan
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
tolvaptan
Product Details
FDA regulatory identification and product classification information